ALBRIOZA Commercial Launch

Significant Unmet Need in the U.S. and Globally ALS is a global disease that affects at least 200,000 people worldwide United States Canada ~29,000 People¹ living with ALS ~3,000 People² living with ALS Affects people globally regardless of ethnic, geographic, or racial background Europe >30,000 People³ living with ALS (European Union and United Kingdom) References: 1. Nelson LM, et al. Neuroepidemiology. 2021 Dec 20. DOI: 10.1159/000521591 2. Shoesmith C, et al. CMAJ Nov 2020, 192 (46) E1453-E1468; DOI: 10.1503/cmaj. 191721 3. Brown CA, et al. Neuroepidemiology. 2021;55(5):342-353. AMYLYX 10

View entire presentation